Published in J Cell Physiol on December 01, 2009
The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification. Circ Res (2011) 0.96
Association of arterial stiffness and osteoporosis in healthy men undergoing screening medical examination. J Bone Metab (2014) 0.80
Prospective evaluation of free radicals and antioxidant activity following 6-month risedronate treatment in patients with postmenopausal osteoporosis. Rheumatol Int (2011) 0.78
Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis. Curr Opin Cardiol (2016) 0.76
Correlation of Arterial Stiffness and Bone Mineral Density by Measuring Brachial-Ankle Pulse Wave Velocity in Healthy Korean Women. Korean J Fam Med (2015) 0.75
Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J (2007) 2.99
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol (2008) 2.96
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
Vascular calcification in chronic kidney disease. Am J Kidney Dis (2004) 1.81
Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med (2010) 1.59
Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation (2002) 1.58
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl (2008) 1.57
Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure. Nephrol Dial Transplant (2007) 1.53
Mechanisms of flavonoid repair reactions with amino acid radicals in models of biological systems: a pulse radiolysis study in micelles and human serum albumin. Biochim Biophys Acta (2002) 1.39
Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients. Nat Clin Pract Nephrol (2006) 1.39
Diagnosis of central hypovolemia by using passive leg raising. Intensive Care Med (2007) 1.39
Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens (2010) 1.21
Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.20
Pulmonary hypertension in CKD. Am J Kidney Dis (2012) 1.19
Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol (2004) 1.16
The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways. J Biol Chem (2008) 1.14
Warning: the unfortunate end of p-cresol as a uraemic toxin. Nephrol Dial Transplant (2011) 1.12
Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins. Clin J Am Soc Nephrol (2011) 1.10
High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells. J Cell Physiol (2008) 1.09
Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem Pharmacol (2003) 1.08
EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib. Int J Cancer (2012) 1.07
Activation of transcription factors and gene expression by oxidized low-density lipoprotein. Free Radic Biol Med (2008) 1.04
p-Cresyl sulfate promotes insulin resistance associated with CKD. J Am Soc Nephrol (2013) 1.04
Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification. Circulation (2008) 1.01
BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinoma. Mol Cancer Res (2010) 1.00
Extracellular calcium promotes the migration of breast cancer cells through the activation of the calcium sensing receptor. Exp Cell Res (2009) 1.00
The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice. Atherosclerosis (2008) 0.99
Inhibition of insulin signaling by oxidized low density lipoprotein. Protective effect of the antioxidant Vitamin E. Atherosclerosis (2004) 0.99
Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J Cell Biochem (2004) 0.99
Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation. Am J Kidney Dis (2005) 0.99
Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. Int J Cancer (2013) 0.97
Photodynamic therapy: Dermatology and ophthalmology as main fields of current applications in clinic. Biomed Mater Eng (2008) 0.97
Extracellular signal-regulated kinases 1 and 2 and TRPC1 channels are required for calcium-sensing receptor-stimulated MCF-7 breast cancer cell proliferation. Cell Physiol Biochem (2009) 0.96
Indoxyl sulphate inhibits osteoclast differentiation and function. Nephrol Dial Transplant (2011) 0.95
Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation. Blood Purif (2010) 0.92
Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro--towards a standardized approach for research on uraemia. Nephrol Dial Transplant (2007) 0.92
Oxidized low density lipoprotein inhibits phosphate signaling and phosphate-induced mineralization in osteoblasts. Involvement of oxidative stress. Biochim Biophys Acta (2010) 0.91
Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease. Biochim Biophys Acta (2013) 0.90
Self-assembly of solid-supported membranes using a triggered fusion of phospholipid-enriched proteoliposomes prepared from the inner mitochondrial membrane. Langmuir (2005) 0.89
The alkyl chain length of 3-alkyl-3',4',5,7-tetrahydroxyflavones modulates effective inhibition of oxidative damage in biological systems: illustration with LDL, red blood cells and human skin keratinocytes. Biochem Pharmacol (2008) 0.89
Review on uraemic solutes II--variability in reported concentrations: causes and consequences. Nephrol Dial Transplant (2007) 0.89
Strontium ranelate decreases receptor activator of nuclear factor-ΚB ligand-induced osteoclastic differentiation in vitro: involvement of the calcium-sensing receptor. Mol Pharmacol (2010) 0.88
Photodynamic therapies: principles and present medical applications. Biomed Mater Eng (2006) 0.88
an Obituary for GFR as the main marker for kidney function? Semin Dial (2011) 0.87
Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity. Eur J Pharmacol (2006) 0.86
Inconsistency of reported uremic toxin concentrations. Artif Organs (2007) 0.86
Oxidized low-density lipoprotein elicits an intracellular calcium rise and increases the binding activity of the transcription factor NFAT. Free Radic Biol Med (2005) 0.86
Relation of serum sodium level to long-term outcome after a first hospitalization for heart failure with preserved ejection fraction. Am J Cardiol (2008) 0.86
Reduced CSF turnover and decreased ventricular Aβ42 levels are related. BMC Neurosci (2011) 0.86
Attenuation of osteoclastogenesis and osteoclast function by apigenin. Biochem Pharmacol (2006) 0.85
Zoledronic Acid and renal toxicity: data from French adverse effect reporting database. Ann Pharmacother (2005) 0.84
Oxidized low density lipoprotein enhanced RANKL expression in human osteoblast-like cells. Involvement of ERK, NFkappaB and NFAT. Biochim Biophys Acta (2013) 0.84
Oxidized low-density lipoprotein increases osteopontin expression by generation of oxidative stress. Free Radic Biol Med (2010) 0.84
Interleukin-7 induces apoptosis of 697 pre-B cells expressing dominant-negative forms of STAT5: evidence for caspase-dependent and -independent mechanisms. Oncogene (2004) 0.82
The Bcl-2 homology domain 3 (BH3) mimetic ABT-737 reveals the dynamic regulation of bad, a proapoptotic protein of the Bcl-2 family, by Bcl-xL. Mol Pharmacol (2011) 0.82
Uremic toxin indoxyl sulfate inhibits human vascular smooth muscle cell proliferation. Ther Apher Dial (2011) 0.82
Upregulation of BAD, a pro-apoptotic protein of the BCL2 family, in vascular smooth muscle cells exposed to uremic conditions. Biochem Biophys Res Commun (2011) 0.81
Total calcium-sensing receptor expression in circulating monocytes is increased in rheumatoid arthritis patients with severe coronary artery calcification. Arthritis Res Ther (2014) 0.81
Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins. Biophys J (2002) 0.81
Nutriose, a prebiotic low-digestible carbohydrate, stimulates gut mucosal immunity and prevents TNBS-induced colitis in piglets. Inflamm Bowel Dis (2010) 0.80
Oxidized low density lipoprotein increases RANKL level in human vascular cells. Involvement of oxidative stress. Biochem Biophys Res Commun (2013) 0.80
Hyperhomocysteinemia in uremia--a red flag in a disrupted circuit. Semin Dial (2009) 0.79
Anti- and pro-oxidant effects of quercetin in copper-induced low density lipoprotein oxidation. Quercetin as an effective antioxidant against pro-oxidant effects of urate. Eur J Biochem (2004) 0.79
Interplay of oxygen, vitamin E, and carotenoids in radical reactions following oxidation of Trp and Tyr residues in native HDL3 apolipoproteins. Comparison with LDL. A time-resolved spectroscopic analysis. Biochemistry (2007) 0.79
Prognostic implication of plasma osteopontin levels in patients with chronic kidney disease. Nephron Clin Pract (2010) 0.79
Potential anti-catabolic and anabolic properties of strontium ranelate. Curr Mol Pharmacol (2012) 0.79
[Recommended dosage adaptation based on renal function is not always sufficient to avoid betalactam antibiotics side effects]. Nephrol Ther (2008) 0.79
Low UVA doses activate the transcription factor NFAT in human fibroblasts by a calcium-calcineurin pathway. Free Radic Biol Med (2005) 0.78
Albumin-bound quercetin repairs vitamin E oxidized by apolipoprotein radicals in native HDL3 and LDL. Biochemistry (2007) 0.78
The use of echocardiography in observational clinical trials: the EURECA-m registry. Nephrol Dial Transplant (2012) 0.78
Phosphate metabolism in chronic kidney disease: from pathophysiology to clinical management. Semin Dial (2009) 0.78
Vascular toxicity of phosphate in chronic kidney disease: beyond vascular calcification . Circ J (2014) 0.77
Structure-activity relationships in hydroxy-2,3-diarylxanthone antioxidants. Fast kinetics spectroscopy as a tool to evaluate the potential for antioxidant activity in biological systems. Org Biomol Chem (2011) 0.77
Beyond phosphate--role of uraemic toxins in cardiovascular calcification. Nephrol Dial Transplant (2006) 0.77
Determination and modulation of total and surface calcium-sensing receptor expression in monocytes in vivo and in vitro. PLoS One (2013) 0.77
Clinical features and prognosis of heart failure in women. A 5-year prospective study. Int J Cardiol (2008) 0.77
The dependence of α-tocopheroxyl radical reduction by hydroxy-2,3-diarylxanthones on structure and micro-environment. Org Biomol Chem (2012) 0.77
Calcium-sensing receptor as a potential modulator of vascular calcification in chronic kidney disease. J Nephrol (2010) 0.77
High circulating levels of large splice variants of tenascin-C is associated with mortality and cardiovascular disease in chronic kidney disease patients. Atherosclerosis (2010) 0.77
Plasma lipoproteins as mediators of the oxidative stress induced by UV light in human skin: a review of biochemical and biophysical studies on mechanisms of apolipoprotein alteration, lipid peroxidation, and associated skin cell responses. Oxid Med Cell Longev (2013) 0.77
Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure. Am J Cardiol (2008) 0.77
Chain-dependent photocytotoxicity of tricationic porphyrin conjugates and related mechanisms of cell death in proliferating human skin keratinocytes. Biochem Pharmacol (2010) 0.76
Uremia-related oxidative stress in leukocytes is not triggered by β2-microglobulin. J Ren Nutr (2013) 0.76
Bone complications of mastocytosis: a link between clinical and biological characteristics. Am J Med (2012) 0.76
Oxidized low density lipoprotein induces cyclin A synthesis. Involvement of ERK, JNK and NFkappaB. Atherosclerosis (2011) 0.76
Oxygen-copper (II) interplay in the repair of semi-oxidized urate by quercetin bound to human serum albumin. Free Radic Res (2004) 0.76
Oxidized low density lipoprotein induces the cyclin-dependent kinase inhibitor p21(waf1) and the tumor suppressor Rb. Biochem Biophys Res Commun (2002) 0.76
Repair of amino acid radicals of apolipoprotein B100 of low-density lipoproteins by flavonoids. A pulse radiolysis study with quercetin and rutin. Biochemistry (2002) 0.76
Anti- and pro-oxidant effects of urate in copper-induced low-density lipoprotein oxidation. Eur J Biochem (2002) 0.76